Doxorubicin
This review highlights the need for enhancements in doxorubicin chemistry, delivery, and toxicity management to prolong its clinical utility against cancer.
Overall the future for the continued use of doxorubicin clinically against cancer looks set to be prolonged, provided certain enhancements as listed above are made to its chemistry, delivery and toxicity. Increased efficacy depends on these three aims being met satisfactorily as discussed in turn in this review.
Building similarity graph...
Analyzing shared references across papers
Loading...
Oktay Tacar
Victoria University
Pornsak Sriamornsak
The Royal College Of Anesthesiologists Of Thailand
Crispin R. Dass
Curtin University
Journal of Pharmacy and Pharmacology
Victoria University
Western Health
Silpakorn University
Building similarity graph...
Analyzing shared references across papers
Loading...
Tacar et al. (Fri,) studied this question.
synapsesocial.com/papers/69d988445e5bcb4e3b836f4c — DOI: https://doi.org/10.1111/j.2042-7158.2012.01567.x
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: